Several spinal conditions often benefit from using SVF adipose-derived stem cell therapy. These include:
· Discogenic pain – In a case study, two patients with discogenic pain received percutaneous lumbar grafts of MSC-containing collagen. The patients had increased signal intensity of discs and decreased pain scores.
· Chronic back pain – In a study involving lumbar pain, patients receiving stem cells had decreased pain scores from 70 to 20 at 12-months post-injection. In addition, mean disability scores decreased significantly.
· Spinal joint disease – Regarding sacroiliac joint disease, and other forms of spinal arthritis, studies show a 50% decrease in pain scores in patients receiving adipose stem cells at 6 months.
· Degenerative disc disease – In a recent clinical study involving stem cells to repair degeneration of the disc in rabbit models, the implanted stem cells were found to have differentiated into disc cells. Other studies have shown that when the stem cells were injected into discs, they exhibited matrix-producing functionality.